# Exenatide and Metformin Therapy in Overweight Women With PCOS

> **NCT00344851** · PHASE2 · COMPLETED · sponsor: **Metabolic Center of Louisiana Research Foundation** · enrollment: 60 (actual)

## Conditions studied

- Polycystic Ovary Syndrome

## Interventions

- **DRUG:** metformin, exenatide or combined (metformin & exenatide )

## Key facts

- **NCT ID:** NCT00344851
- **Lead sponsor:** Metabolic Center of Louisiana Research Foundation
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-06
- **Primary completion:** —
- **Final completion:** 2007-06
- **Target enrollment:** 60 (ACTUAL)
- **Last updated:** 2007-07-11

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00344851

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00344851, "Exenatide and Metformin Therapy in Overweight Women With PCOS". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00344851. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*